Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Second Primary Neoplasms. Found 11 abstracts

Jung K, Park JC, Kang H, Brandes JC. Androgen deprivation therapy is associated with decreased second primary lung cancer risk in the United States veterans with prostate cancer. Epidemiology and health. 2018 Aug;40:e2018040.   PMCID: PMC6232654
Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ, Jervis S, van Leeuwen FE, Milne RL, Andrieu N, Goldgar DE, Terry MB, Rookus MA, Easton DF, Antoniou AC, Brca, Brca Cohort Consortium, McGuffog L, Evans DG, Barrowdale D, Frost D, Adlard J, Ong KR, Izatt L, Tischkowitz M, Eeles R, Davidson R, Hodgson S, Ellis S, Nogues C, Lasset C, Stoppa-Lyonnet D, Fricker JP, Faivre L, Berthet P, Hooning MJ, van der Kolk LE, Kets CM, Adank MA, John EM, Chung WK, Andrulis IL, Southey M, Daly MB, Buys SS, Osorio A, Engel C, Kast K, Schmutzler RK, Caldes T, Jakubowska A, Simard J, Friedlander ML, McLachlan SA, Machackova E, Foretova L, Tan YY, Singer CF, Olah E, Gerdes AM, Arver B, Olsson H. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers. Jama. 2017 Jun 20;317(23):2402-16.
Shih J, Bashir B, Gustafson KS, Andrake M, Dunbrack RL, Goldstein LJ, Boumber Y. Cancer Signature Investigation: ERBB2 (HER2)-Activating Mutation and Amplification-Positive Breast Carcinoma Mimicking Lung Primary. J Natl Compr Canc Netw. 2015 Aug;13(8):947-52.   PMCID: 4763101
Tomaszewski JJ, Uzzo RG, Egleston B, Corcoran AT, Mehrazin R, Geynisman DM, Ridge JA, Veloski C, Kocher N, Smaldone MC, Kutikov A. Coupling of Prostate and Thyroid Cancer Diagnoses in the United States. Annals of Surgical Oncology. 2015 Mar;22(3):1043-9.   PMCID: 4419700
Vijayvergia N, Shah PC, Denlinger CS. Survivorship in Non-Small Cell Lung Cancer: Challenges Faced and Steps Forward. J Natl Compr Canc Netw. 2015 Sep;13(9):1151-61.
Rubins J, Unger M, Colice GL. Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guideline (2nd edition). Chest. 2007 Sep;132(3 Suppl):355S-367S.
Borghaei H, Wallace SG, Schilder RJ. Factors associated with toxicity and response to yttrium 90-labeled ibritumomab tiuxetan in patients with indolent non-Hodgkin's lymphoma. Clinical Lymphoma. 2004 Oct;5 Suppl 1:S16-21.
Colice GL, Rubins J, Unger M. Follow-up and surveillance of the lung cancer patient following curative-intent therapy. Chest. 2003 Jan;123(1 Suppl):272S-283S.
Carbone M, Kratzke RA, Testa JR. The pathogenesis of mesothelioma. Semin Oncol. 2002 Feb;29(1):2-17.
Fowble B, Hanlon A, Freedman G, Nicolaou N, Anderson P. Second cancers after conservative surgery and radiation for stages I-II breast cancer: identifying a subset of women at increased risk. Int J Radiat Oncol Biol Phys. 2001 Nov;51(3):679-90.
Kaminski JM, Yang CC, Yagmai F, Movsas B, Lee M, Barrett JT. Intracranial fibrosarcoma arising 5 years after chemotherapy alone for glioblastoma multiforme in a child. Pediatr Neurosurg. 2000 Nov;33(5):257-60.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Second Primary Neoplasms

Second Primary Neoplasms epidemiology Lung Neoplasms Aged Female therapy diagnosis Human Follow-Up Studies adverse effects Risk Factors Breast Neoplasms drug therapy Treatment Outcome genetics Adult Age Factors Incidence Male Middle Aged Non-Small-Cell Lung Carcinoma Time Factors surgery prevention & control etiology Combined Modality Therapy Mutation Neoplasm Staging Prostatic Neoplasms Smoking Cessation Prognosis Risk therapeutic use United States Local Neoplasm Recurrence Pneumonectomy Brain Neoplasms Prospective Studies 0 (ibritumomab tiuxetan) complications Life Style ErbB-2 Receptor Simian virus 40 US Gov't Support-PHS Occipital Lobe Animal Radiotherapy Age Distribution Monoclonal Antibodies psychology Bone Marrow Transplantation statistics & numerical data Thyroid Neoplasms CD20) 0 (Antigens Radiosurgery Thoracic Radiography virology Genetic Testing Dyspnea Antineoplastic Agents Ovarian Neoplasms pd [Pharmacology] BRCA2 Genes mt [Methods] Androgen Antagonists Monoclonal) 0 (Antibodies Tumor Suppressor Genes Glioblastoma Antineoplastic Combined Chemotherapy Protocols Mesothelioma Segmental Mastectomy radiotherapy Androgen antagonists X-Ray Computed Tomography Case Report BRCA1 Genes Evidence-Based Medicine Lobular Carcinoma Adjuvant Chemotherapy Turkey Non-US Gov't Support Quality of Life Infiltrating Duct Carcinoma Hormones Fatigue im [Immunology] Frontal Lobe Radioimmunotherapy Motor Activity Biopsy Gene Amplification Middle Age Fear Health Behavior Guilt 80 and over Aged secondary 0 (Yttrium Radioisotopes) Tumor Virus Infections Infant pathology mortality Fibrosarcoma ae [Adverse Effects] Asbestos Lymph Node Excision Family SEER Program tu [Therapeutic Use] Lung neoplasms Risk Assessment Smoking Radiation-Induced Neoplasms Polyomavirus Infections Veterans Prostatic neoplasms Magnetic Resonance Imaging CD20 Antigens Animal Disease Models Pain Non-Hodgkin Lymphoma Zeolites Axilla Registries Survivors rt [Radiotherapy] Yttrium Radioisotopes Occupational Exposure Pleural Neoplasms Lymphatic Irradiation
Last updated on Friday, August 07, 2020